CD8A and neoplasm: Mechanisms of resistance to these therapies are being identified in model systems and clinical studies, and include a lack of infiltrating CD8+ T-cells or the presence of exhausted CD8+ T-cells within the tumor, which appear to be crucial for strong responses [8,9,10,11].